Natpara

Active Ingredient(s): Parathyroid Hormone
FDA Approved: * January 23, 2015
Pharm Company: * NPS PHARMS INC
Category: Thyroid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Natpara Overview

Recombinant human parathyroid hormone, marketed under the trade name Natpara, is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism.[1][2] References ^ "FDA approves Natpara to control low blood calcium levels in patients with hypoparathyroidism". http://www.fda.gov/. Retrieved 30 January 2015. External link in |website= (help).mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation ...

Read more Natpara Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Recombinant_human_parathyroid_hormone

Recent Natpara Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Parathyroid Hormone
  • Injection: 100mcg, 25mcg, 50mcg, 75mcg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Parathyroid Hormone or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 July 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA